A human laboratory pilot study with baclofen in alcoholic individuals

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 4, 2013, Pages 784-791

  Leggio, Lorenzo ^a   Zywiak, William H ^a,b   McGeary, John E ^a,c   Edwards, Steven ^a   Fricchione, Samuel R ^a   Shoaff, Jessica R ^a   Addolorato, Giovanni ^d   Swift, Robert M ^a,c   Kenna, George A ^a  

^a BROWN UNIVERSITY   (United States)

^b Pacific Institute for Research and Evaluation   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alcohol self administration; Alcoholism; Baclofen; Biobehavioral mechanisms; Cue reactivity; Genetic polymorphisms

Indexed keywords

BACLOFEN; CYPROHEPTADINE; DOPAMINE 4 RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG MECHANISM; FEMALE; GENETIC POLYMORPHISM; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; STIMULATION; TREATMENT DURATION;

ADULT; ALCOHOL DRINKING; ALCOHOLICS; ALCOHOLISM; BACLOFEN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GABA-B RECEPTOR AGONISTS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 84873326184     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.11.013     Document Type: Article

References (50)

1. G. Addolorato, F. Caputo, E. Capristo, G. Colombo, G.L. Gessa, and G. Gasbarrini Ability of baclofen in reducing alcohol craving and intake: II - preliminary clinical evidence Alcohol Clin Exp Res 24 2000 67 71
2. G. Addolorato, F. Caputo, E. Capristo, M. Domenicali, M. Bernardi, and L. Janiri Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study Alcohol Alcohol 37 2002 504 508
3. G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, L. Vonghia, and A. Mirijello Effectiveness and safety of BACL for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study Lancet 370 2007 1915 1922
4. G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, G. Bedogni, and F. Caputo Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial Alcohol Alcohol 46 2011 312 317
5. O. Ameisen Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician Alcohol Alcohol 40 2005 147 150
6. M.J. Bohn, D.D. Krahn, and B.A. Staehler Development and initial validation of a measure of drinking urges in abstinent alcoholics Alcohol Clin Exp Res 19 1995 600 606
7. F.K. Del Boca, H.R. Kranzler, J. Brown, and P.F. Korner Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer Alcohol Clin Exp Res 20 1996 1412 1417
8. S.M. Evans, and A. Bisaga Acute interaction of baclofen in combination with alcohol in heavy social drinkers Alcohol Clin Exp Res 33 2009 19 30
9. M.B. First, R.I. Spitzer, M. Gibbon, and J.B.W. Williams Structured clinical interview for DSM-IV axis I disorders-patient edition (SCID-I/P, version 2.0) 1994 New York State Psychiatric Institute, Biometrics Research Department New York
10. B.A. Flannery, J.C. Garbutt, M.W. Cody, W. Renn, K. Grace, and M. Osborne Baclofen for alcohol dependence: a preliminary open-label study Alcohol Clin Exp Res 28 2004 1517 1523
11. B. Freeman, J. Powell, D. Ball, L. Hill, I. Craig, and R. Plowmin DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations Behav Genet 27 1997 251 257
12. J.C. Garbutt, A.B. Kampov-Polevoy, R. Gallop, L. Kalka-Juhl, and B.A. Flannery Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial Alcohol Clin Exp Res 34 2010 1849 1857
13. D.T. George, D.W. Herion, C.L. Jones, M.J. Phillips, J. Hersh, and D. Hill Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers Psychopharmacology (Berl) 208 2010 37 44
14. D. Gleeson, J.S. Jones, E. McFarlane, R. Francis, C. Gellion, and M.P. Bradley Severity of alcohol dependence in decompensated alcoholic liver disease: comparison with heavy drinkers without liver disease and relationship to family drinking history Alcohol Alcohol 44 2009 392 397
15. A. Hammarberg, N. Jayaram-Lindström, O. Beck, J. Franck, and M.S. Reid The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial Psychopharmacology (Berl) 205 2009 53 62
16. K.E. Hutchison, J. McGeary, A. Smolen, A. Bryan, and R.M. Swift The DRD4 VNTR polymorphism moderates craving after alcohol consumption Health Psychol 21 2002 139 4146
17. K.E. Hutchison, A. Wooden, R.M. Swift, A. Smolen, J. McGeary, and L. Adler Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction Neuropsychopharmacology 28 2003 1882 1888
18. P.R. Johnson, S. Banu, and M.V. Ashok Severity of alcoholism in Indian males: correlation with age of onset and family history of alcoholism. 1 Indian J Psychiatry 52 2010 243 249
19. G.A. Kenna, W.H. Zywiak, J.E. McGeary, L. Leggio, C. McGeary, and S. Wang A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline Alcohol Clin Exp Res 33 2009 315 323
20. G.A. Kenna, N. Hanna-Roder, L. Leggio, W.H. Zywiak, J. Clifford, and S. Edwards Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy Pharmacogenomics Pers Med 5 2012 19 35
21. C.M. Knapp, K. Lee, M. Foye, D.A. Ciraulo, and C. Kornetsky Additive effects of intra accumbens infusion of the cAMP-specific phosphodiesterae inhibitor, rolipam, and cocaine on brian stimulation reward Life Sci 69 2001 1673 1682
22. L. Leggio, A. Ferrulli, S. Cardone, A. Miceli, G.A. Kenna, and G. Gasbarrini Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study Alcohol 42 2008 375 381
23. L. Leggio, A. Ferrulli, N. Malandrino, A. Miceli, E. Capristo, and G. Gasbarrini Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients Alcohol Clin Exp Res 32 2008 450 458
24. L. Leggio, G.A. Kenna, M. Fenton, E. Bonenfant, and R.M. Swift Typologies of alcohol dependence. From jellinek to genetics and beyond Neuropsychol Rev 19 2009 115 129
25. L. Leggio, J.C. Garbutt, and G. Addolorato Effectiveness and safety of baclofen in the treatment of alcohol dependent patients CNS Neurol Disord Drug Targets 9 2010 33 44
26. L. Leggio, A. Ferrulli, A. Zambon, F. Caputo, G.A. Kenna, and R.M. Swift Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection Addict Behav 37 2012 561 564
27. N. Lench, P. Stanier, and R. Williamson Simple noninvasive method to obtain DNA for gene analysis Lancet 1 1988 1356 1358
28. P. Maccioni, and G. Colombo Role of the GABA(B) receptor in alcohol-seeking and drinking behavior Alcohol 43 2009 555 558
29. R.E. Mann, L.C. Sobell, M.B. Sobell, and D. Pavan Reliability of a family tree questionnaire for assessing family history of alcohol problems Drug Alcohol Depend 15 1985 61 67
30. C.S. Martin, M. Earleywine, R.E. Musty, M.W. Perrine, and R.M. Swift Development and validation of the Biphasic Alcohol Effects Scale Alcohol Clin Exp Res 17 1993 140 146
31. G. Martinotti, M.D. Nicola, D. Reina, S. Andreoli, F. Focà, and A. Cunniff Alcohol protracted withdrawal syndrome: the role of anhedonia Subst Use Misuse 43 2008 271 284
32. J. McGeary The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review Pharmacol Biochem Behav 93 2009 222 229
33. J.E. McGeary, P.M. Monti, D.J. Rohsenow, J. Tidey, R. Swift, and R. Miranda Jr. Genetic moderators of naltrexone's effects on alcohol cue reactivity Alcohol Clin Exp Res 30 2006 1288 1296
34. W.R. Miller, and G.A. Marlatt Manual for the comprehensive drinker profile 1984 Psychological Assessment Resources Odessa, FLA
35. P.M. Monti, J.A. Binkoff, D.B. Abrams, W.R. Zwick, T.D. Nirenberg, and M.R. Liepman Reactivity of alcoholics and nonalcoholics to drinking cues J Abnorm Psychol 96 1987 122 126
36. P.M. Monti, D.J. Rohsenow, K.E. Hutchison, R.M. Swift, T.I. Mueller, and S.M. Colby Naltrexone's effect on cue-elicited craving among alcoholics in treatment Alcohol Clin Exp Res 23 1999 1386 1394
37. S.S. O'Malley, S. Krishnan-Sarin, C. Farren, R. Sinha, and J. Kreek Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamopituitary-adrenocortical axis Psychopharmacology 160 2002 19 29
38. K.A. Perkins, M. Stitzer, and C. Lerman Medication screening for smoking cessation: a proposal for new methodologies Psychopharmacology (Berl) 184 2006 628 636
39. L. Ray, A. Bryan, J. Mackillop, J. McGeary, K. Hesterberg, and K.E. Hutchison The dopamine D4 receptor (DRD4) gene exon III polymorphism, problematic alcohol use, and novelty seeking: direct and mediated genetic effects Addict Biol 14 2009 238 244
40. L. Rigal, C. Alexandre-Dubroeucq, R. de Beaurepaire, C. Le Jeunne, and P. Jaury Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers Alcohol Alcohol 2012 47 2012 439 442
41. D.J. Rohsenow, P.M. Monti, D.B. Abrams, A.V. Rubonis, R.S. Niaura, and A.D. Sirota Cue elicited urge to drink and salivation in alcoholics: relationship to individual differences Adv Behav Res Ther 14 1992 195 210
42. M.A. Schuckit, C. Mazzanti, T.L. Smith, U. Ahmed, M. Radel, and N. Iwata Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABAa6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study Biol Psychiatry 45 1999 647 651
43. M.A. Schuckit, T.L. Smith, K.G. Anderson, and S.A. Brown Testing the level of response to alcohol: social information processing model of alcoholism risk - a 20-year prospective study Alcohol Clin Exp Res 28 2004 1881 1889
44. J. Serrats, F. Artigas, G. Mengod, and R. Cortes GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase J Neurochem 84 2003 743 752
45. H.A. Skinner, and B.A. Allen Alcohol dependence syndrome: measurement and validation J Abnorm Psychol 91 1982 199 209
46. C.D. Spielberg, R.L. Gorsuch, and R.E. Lushene Manual for the state and trait anxiety inventory 1983 Consulting Psychologist Press Paolo Alto (CA)
47. R.L. Stout, P.W. Wirtz, J.P. Carbonari, and F.K. Del Boca Ensuring balanced distribution of prognostic factors in treatment outcome research J Stud Alcohol Supplement No. 12 1994 70 75
48. P.E. Watson Total body water and blood alcohol levels: updating the fundamentals K. Crow, R. Batt, Human metabolism of alcohol (Vol. 1): pharmacokinetics, medicolegal aspects, and general interest 1989 CRC Press Boca Raton, FL 41 58
49. K.D. White Salivation: a review and experimental investigation of major techniques Psychophysiology 14 1977 203 212
50. M. Yoshida, H. Yokoo, T. Tanaka, H. Emoto, and M. Tanaka Opposite changes in the mesolimbic metabolism in the nerve terminal and cell body sites induced by locally infused in the rat Brain Res 636 1994 111 114